NOTE TO EDITORS: The Following is An Investment Opinion Issued by Spruce Point Capital Management
Publishes Recently Released Freedom Of Information Act Request From The Kentucky Department Of Environmental Protection, Which Provides Smoking Gun Evidence That Danimer Lacks Proper Controls On Its Own Production Figures
Evidence Shows Danimer’s PHA Average Selling Price Is Actually Up To 42% Below Management’s Claims
Certified PHA Production Figures Show That Danimer Is Operating Significantly Below Current Capacity Despite Recently Claiming It Is “Fully Sold-Out”
Warns Investors That 12 Million Warrants Become Exercisable at $11.50 After This Friday, May 7, 2021
Notes That Danimer Has Failed To Issue A Public Response To Any Of Our Claims Since The Publication Of Our Initial Report On April 22, 2021
Urges Investors To Visit www.SprucePointCap.com to Review New Evidence And Follow @SprucePointCap On Twitter For The Latest On $DNMR
May 04, 2021 10:30 AM Eastern Daylight Time
NEW YORK--(BUSINESS WIRE)--Spruce Point Capital Management, LLC (“Spruce Point” or “we” or “us”), a New York-based investment management firm that focuses on forensic research and short-selling, today released new evidence in a supplemental report entitled "When The Tide Goes Out, What Will Wash Ashore?” that explains why Danimer Scientific, Inc.’s (NYSE: DNMR) ("Danimer" or the "Company") production figures, its pricing, and rosy financial projections simply do not add up. We reiterate 65% intermediate and 100% long-term downside risk to Danimer’s share price. Download or view the report by visiting www.SprucePointCap.com and follow us on Twitter @SprucePointCap for additional information and exclusive updates.
Ben Axler, Spruce Point’s Founder and Chief Investment Officer, commented:
“Evidence uncovered since the release of our initial report only reaffirms our belief that Danimer has been peddling an inconsistent, ever-changing story to investors that will likely fail to deliver on its promises. Danimer’s certified production figures and other evidence recently released by the Kentucky Department of Environmental Protection indicate that the Company has been overstating PHA average selling prices by up to 42% and illuminate that the Company’s monthly biopolymer production and natural gas usage for its Kentucky facility have been materially misreported. Evidence released from the FOIA also shows that Danimer received violation notices in Kentucky, raising serious concerns regarding the Company’s environmental regulation claims. Ironically, Danimer positions itself as an environmentally friendly biodegradable product solution, but fails to disclose that its own production process omits Volatile Organic Compounds that must be stringently regulated by the Environmental Protection Agency.
We believe these latest findings only further invalidate sell-side analysts’ inflated share price targets for Danimer, which rely on average selling prices that the Company’s own certified data show are overstated by up to 42%. We encourage investors to review new evidence Spruce Point has made available and to seriously question why Danimer is telling investors it needs hundreds of millions of dollars in capacity expansion when recently reported production figures are so far below their actual capacity.”
Spruce Point urges investors to review new findings in its report, including:
The research note can be found at www.sprucepointcap.com and updates will be posted on twitter @sprucepointcap.
See the other side of the Wall Street hype machine.